IOVS AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2005;46:2253-2257.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-1460
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilic, E.
Right arrow Articles by de Klein, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilic, E.
Right arrow Articles by de Klein, A.

Concurrent Loss of Chromosome Arm 1p and Chromosome 3 Predicts a Decreased Disease-Free Survival in Uveal Melanoma Patients

Emine Kilic,1,2,3 Nicole C. Naus,1,3 Walter van Gils,2 Caroline C. Klaver,1 Marjan E. van Til,2 Michael M. Verbiest,2 Theo Stijnen,4 Cornelia M. Mooy,5 Dion Paridaens,6 H. Berna Beverloo,2 Gregorius P. Luyten,1 and Annelies de Klein2

1From the Departments of Ophthalmology, 2Clinical Genetics, 4Epidemiology and Biostatistics, 5Ophthalmopathology, Erasmus MC, Rotterdam, The Netherlands; and the 6Rotterdam Eye Hospital, Rotterdam, The Netherlands.

PURPOSE. Uveal melanoma is a highly malignant disease with a mortality rate of 50% at 10 to 15 years. Previous studies have shown that chromosomal changes are associated with decreased survival of the patient. However, in these studies the small number of tumors analyzed did not allow robust statistical analysis. In the present study, the independent numerical changes in chromosomes 1, 3, 6, and 8 on disease-free survival (DFS) was assessed in a large series of patients with uveal melanoma.

METHODS. One hundred twenty tumors from patients with uveal melanoma were analyzed for numerical changes in chromosomes 1, 3, 6, and 8, with cytogenetic analysis, fluorescent in situ hybridization, and/or comparative genomic hybridization. Data were correlated with disease outcome in univariate and multivariate analyses, by Kaplan-Meier and Cox regression analyses.

RESULTS. At a mean follow-up time of 45 months, 42 patients had died or had metastatic disease. In the univariate analysis, loss of chromosome 3, gain of 8q, largest tumor diameter, or the presence of epithelioid cells was associated with a decreased DFS. In the multivariate analysis, the effect of monosomy 3 on survival was largely modified by changes in 1p36. Regarding all chromosomal changes, only the concurrent loss of the short arm of chromosome 1 and all of chromosome 3 was an independent prognostic parameter for disease-free survival (P < 0.001).

CONCLUSIONS. In uveal melanoma, concurrent loss of the short arm of chromosome 1 and all of chromosome 3 is an independent predictor of decreased DFS.




This article has been cited by other articles:


Home page
 IOVSHome page
B. Damato, J. Dopierala, A. Klaasen, M. van Dijk, J. Sibbring, and S. E. Coupland
Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3048 - 3055.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Trolet, P. Hupe, I. Huon, I. Lebigot, C. Decraene, O. Delattre, X. Sastre-Garau, S. Saule, J.-P. Thiery, C. Plancher, et al.
Genomic Profiling and Identification of High-Risk Uveal Melanoma by Array CGH Analysis of Primary Tumors and Liver Metastases
Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2572 - 2580.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. van Gils, E. M. Lodder, H. W. Mensink, E. Kilic, N. C. Naus, H. T. Bruggenwirth, W. van IJcken, D. Paridaens, G. P. Luyten, and A. de Klein
Gene Expression Profiling in Uveal Melanoma: Two Regions on 3p Related to Prognosis
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4254 - 4262.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. van Gils, H. W. Mensink, E. Kilic, J. Vaarwater, M. M. Verbiest, D. Paridaens, G. P. Luyten, A. de Klein, and H. T. Bruggenwirth
Expression of APITD1 Is Not Related to Copy Number Changes of Chromosomal Region 1p36 or the Prognosis of Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4919 - 4923.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. Maat, P. A. van der Velden, C. Out-Luiting, M. Plug, A. Dirks-Mulder, M. J. Jager, and N. A. Gruis
Epigenetic Inactivation of RASSF1a in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 486 - 490.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Kilic, W. van Gils, E. Lodder, H. B. Beverloo, M. E. van Til, C. M. Mooy, D. Paridaens, A. de Klein, and G. P. M. Luyten
Clinical and cytogenetic analyses in uveal melanoma.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3703 - 3707.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology